TREATMENT OF DIARRHOEA IN INDONESIAN CHILDREN: WHAT IT COSTS AND WHO PAYS FOR IT

34Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The annual economic burden of diarrhoea in four subdistricts in Indonesia averaged $2·27 per child aged under 5 years when health centre, hospital, and private expenditures were all considered. The community itself spent $1·03 per child or 46% of the total; 96% of community payments went to the private sector, and 4% were for fees at government health centres and hospitals. The widespread availability of oral rehydration therapy has led to only partial abandonment of ineffective or marginally effective medications; non-rehydration medications amounted to 44% of total treatment expenditures. Most medication costs were for antimicrobial agents, such as tetracycline in the government sector and iodo-chlorhydroxyquin in the private sector. If the use of tetracycline at health centres could be restricted to 10% of episodes treated instead of the present 88%, their costs could be reduced by 50%. © 1985.

Cite

CITATION STYLE

APA

Lerman, S. J., Shepard, D. S., & Cash, R. A. (1985). TREATMENT OF DIARRHOEA IN INDONESIAN CHILDREN: WHAT IT COSTS AND WHO PAYS FOR IT. The Lancet, 326(8456), 651–654. https://doi.org/10.1016/S0140-6736(85)90013-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free